Rewards haven’t provided big boost for Nevada COVID-19 vaccinations
Gov. Steve Sisolak’s offer of a chance to win a million-dollar prize hasn’t resulted in a noticeable uptick in COVID-19 vaccinations in Nevada, at least not so far.
Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.
An audio journey of how data and analytics save lives, save money and solve problems.

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
Gov. Steve Sisolak’s offer of a chance to win a million-dollar prize hasn’t resulted in a noticeable uptick in COVID-19 vaccinations in Nevada, at least not so far.
On Thursday, President Joe Biden beseeched Americans to meet his deadline of having 70 percent of American adults partly or fully vaccinated against the coronavirus by July 4. In a speech, he asked Americans to "knock on doors and talk to friends and neighbors" about getting vaccinated so that the country can reach the much-touted 70 percent threshold — which, public health experts say, marks the point at which the novel coronavirus will slow down and eventually cease in its spread.
When an N95 respirator shortage left hospitals scrambling in 2020, U.S. manufacturers stepped in. Now, those companies are facing bankruptcies and layoffs as Chinese-made masks flood the market again.
The vaccine rollout effort has disrupted the medicine supply chain. Pharmaceutical giant Pfizer is now reporting shortages of birth control after the company reorganized its priorities to producing COVID-19 shots.
On May 27, the Strategic Advisory Group of Experts on Immunization met virtually to discuss global COVID-19 vaccine distribution and inequity. Talha Burki reports.

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine